查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1863491

泌尿系统护理设备和平台市场（按产品类型、应用、最终用户、手术类型和技术划分）－2025-2032年全球预测

Urology Care Devices & Platforms Market by Product Type, Application, End User, Procedure Type, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，泌尿系统护理设备和平台市场将成长至 765.8 亿美元，复合年增长率为 6.08%。

关键市场统计数据
基准年 2024 477.4亿美元
预计年份：2025年 505.9亿美元
预测年份 2032 765.8亿美元
复合年增长率 (%) 6.08%

本书精闢地介绍了人口压力、临床创新和不断变化的医疗模式如何重新定义泌尿系统器械和平台的发展重点。

现代泌尿系统生态系统正处于一个转折点，临床需求、技术创新和不断演变的医疗服务模式在此交汇融合。人口老化和慢性泌尿系统系统疾病的盛行率上升推动了临床病例数量的增长，而诊断技术、影像学和微创手术的进步正在改变临床医生检测、治疗和管理疾病的方式。同时，医疗系统日益注重价值导向，推动医疗机构和设备朝向能够缩短住院时间、降低併发症率并支持门诊和居家医疗的方向发展。

在此背景下，医疗设备开发商和平台提供者正在重新思考产品架构、连接方式和服务模式。数位化正在加速医疗设备的智慧化进程，从而实现更精准的诊断并促进远端监测。同时，法规结构和支付模式也在不断发展，以应对安全性、真实世界数据和基于结果的报销等问题，这影响着研发重点和商业化策略。这些趋势正在重塑研发投资、供应商伙伴关係和临床应用路径。

展望未来，能够整合临床证据、互通性并采用以患者为中心的设计的相关人员将最有能力影响医疗路径。此外，积极协调供应链韧性和监管准备工作的组织将能够减轻中断影响并维持其创新管道。本执行摘要的其余部分说明探讨结构性变化、细分市场的影响、区域差异以及应对此快速变化环境的建议措施。

对正在重塑泌尿系统临床路径、设备设计和商业性重点的重大技术和製度变革进行深入分析。

泌尿系统器械和平台格局正经历重大变革，这些变革既包括技术层面，也包括系统层面。首先，内视镜光学技术的改进、雷射碎石术的进步以及高解析度成像系统的发展，推动了微创影像导引手术的成熟，提高了诊断准确性并减少了手术併发症。因此，临床路径越来越重视促进復健和实现门诊治疗的介入措施。

其次，数位技术和数据驱动能力正从辅助功能转变为核心产品差异化因素。互联诊断设备、云端工作流程平台和人工智慧辅助影像分析正在提高诊断效率，并支援更个人化的治疗方案。这些能力也不断产生真实世界证据，而支付方和监管机构也开始要求提供这些证据，这将影响报销和实施时间表。

第三，医疗服务模式日趋分散化。门诊手术中心、诊断中心和家庭护理的重要性日益凸显，推动了导管技术、携带式影像设备和小型体外碎石系统的重新设计。最后，监管机构对上市后监管和互通性标准的重视正在影响产品蓝图和供应商联盟，製造商在重视临床性能的同时，也优先考虑合规性和资料安全。这些变化共同塑造了一个全新的格局：技术卓越、互通性和对新医疗环境的适应能力将决定企业的长期竞争力。

对 2025 年美国关税制度如何重塑泌尿系统器械製造的供应链、筹资策略和业务永续营运韧性进行分析评估。

美国关税将于2025年生效，对整个泌尿系统医疗设备及平台价值链产生多面向影响。关税带来的成本压力不仅限于成品，还波及影像处理子系统、雷射模组和一次性导管材料等关键零件。因此，采购团队和产品经理面临新的挑战：重新评估供应商组合、重新计算总到岸成本，并加快替代供应商的资格认证。

这些趋势也将对策略决策产生影响。为避免关税波动的影响，製造商可能会寻求扩大本地生产或近岸外包，这将需要资本投资和重新思考供应链规划。同时，透过采购整合和长期供应协议来节省采购成本可以部分抵消不断上涨的投入成本，但这些安排需要严格的合约管理和品质监控。

医疗专业人员和供应商将受到间接影响，采购限制和库存管理挑战会影响医疗设备的供应和前置作业时间。为了减少对临床营运的干扰，各机构正在优先实施供应链视觉化工具、安全库存通讯协定和多源策略。此外，成本上升也可能影响创新路径，因为研发预算将重新分配到使用标准化、免税零件的模组化设计。总而言之，关税将促进供应链转型、策略营运调整以及加强製造业韧性。

透过整合产品类型、临床应用、最终用户、手术类型和底层技术进行全面的細項分析，为有针对性的策略决策提供支援。

在泌尿系统领域，深入的市场细分对于了解产品开发重点、临床应用和服务至关重要。本市场研究以产品类型，涵盖诊断设备、内视镜、影像设备、体外碎石设备、尿道导管和尿道支架。诊断设备进一步细分为生物标记检测、pH计、尿流率计和尿动力学检查系统。内视镜检验包括膀胱镜、肾臟镜和输尿管镜。影像设备包括CT扫描系统、MRI系统、超音波系统和X光系统。体外碎石技术包括体外震波碎石、雷射碎石、气压碎石和超音波碎石。尿道导管也进行了全面分析，包括尿套式导管、 Foley导管、间歇性导尿管、肾造瘻导管和输尿管导管。对尿道支架进行了全面检查，包括前列腺支架、输尿管支架和尿道支架。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧驱动的诊断技术应用于前列腺癌和肾结石的早期检测
  • 推出远距泌尿系统平台，提供远距会诊和病患监测
  • 开发专门用于复杂泌尿系统手术的微创机器人手术系统
  • 穿戴式尿失禁监测设备的普及率不断提高，这些设备可提供即时分析数据，从而优化治疗方案。
  • 推出先进的智慧导管解决方案，旨在减少感染疾病并提高患者舒适度
  • 扩展照护现场检测平台，用于快速诊断尿道感染
  • 云端基础的病患管理软体实现泌尿系统护理协调与分析的一体化

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章泌尿系统护理设备与平台市场（依产品类型划分）

  • 诊断
    • 生物标记检测
    • pH计
    • 尿流量计
    • 尿动力学测试系统
  • 内视镜检查
    • 膀胱镜
    • 肾镜
    • 输尿管镜
  • 影像诊断
    • 电脑断层扫描系统
    • 磁振造影系统
    • 超音波诊断设备
    • X射线系统
  • 体外碎石术
    • 体外震波碎石术
    • 雷射碎石术
    • 气动碎石术
    • 超音波碎石术
  • 导尿管
    • 保险套导尿管
    • Foley导管
    • 间歇性导尿管
    • 肾造瘻管
    • 输尿管导管
  • 尿路支架
    • 摄护腺支架
    • 输尿管支架
    • 尿道支架

第九章泌尿系统护理设备和平台市场（按应用领域划分）

  • 良性摄护腺增生
  • 肾癌
    • 肾臟细胞癌
    • 移行细胞癌
    • 威尔姆氏肿瘤
  • 肾结石治疗
    • 钙结石
    • 胱氨酸结石
    • 鸟粪石
    • 尿酸结石
  • 膀胱过动症
    • 特发性
    • 神经源性
  • 摄护腺癌
    • 在地化
    • 转移性
    • 復发
  • 尿道狭窄
    • 医源性
    • 特发性
    • 创伤
  • 尿失禁
    • 混合性尿失禁
    • 溢出性尿失禁
    • 应力性尿失禁
    • 急性尿失禁
  • 尿道感染
    • 併发症
    • 无併发症

第十章泌尿系统护理设备与平台市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 诊断中心
  • 居家医疗
  • 医院

第十一章泌尿系统护理设备与平台市场（依手术类型划分）

  • 侵入性
    • 导管介入治疗
    • 开放性手术
  • 微创
    • 内视镜手术
    • 腹腔镜手术
    • 经皮手术
  • 非侵入性
    • 保守治疗
    • 体外震波疗法
    • 影像诊断

第十二章泌尿系统护理设备与平台市场（依技术划分）

  • 电液式
    • 高频电液
    • 标准电液
  • 雷射
    • 二氧化碳雷射
    • 绿色雷射
    • 钬雷射
    • 铥雷射
  • 磁振造影
    • 磁共振波谱
    • 磁共振引导磁共振
  • 光学
    • 萤光光学
    • 窄频成像
    • 白光光学
  • 气压
    • 弹道气压
    • 振动气动
  • 高频
    • 双极射频
    • 单极射频
  • 超音波
    • 高强度超音波
    • 低强度超音波

第十三章泌尿系统护理设备与平台市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章泌尿系统护理设备与平台市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国泌尿系统护理设备与平台市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Boston Scientific Corporation
    • Olympus Corporation
    • Medtronic plc
    • Coloplast A/S
    • Becton, Dickinson and Company
    • Teleflex Incorporated
    • ConvaTec Group plc
    • Intuitive Surgical, Inc.
    • Stryker Corporation
    • Johnson & Johnson
Product Code: MRR-5C6F41F5B0B4

The Urology Care Devices & Platforms Market is projected to grow by USD 76.58 billion at a CAGR of 6.08% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 47.74 billion
Estimated Year [2025] USD 50.59 billion
Forecast Year [2032] USD 76.58 billion
CAGR (%) 6.08%

An incisive introduction to how demographic pressures, clinical innovation, and shifting care models are redefining urology device and platform priorities

The contemporary urology care ecosystem is at an inflection point where clinical demand, technological innovation, and delivery model evolution intersect. Aging populations and rising prevalence of chronic urological conditions are expanding clinical caseloads, while advances in diagnostics, imaging, and minimally invasive therapies are changing how clinicians detect, treat, and manage disease. At the same time, health systems emphasize value, driving a shift toward procedures and devices that reduce length of stay, lower complication rates, and support outpatient and home-based care.

Against this backdrop, device developers and platform providers are rethinking product architecture, connectivity, and service models. Digitalization is accelerating device intelligence, enabling more precise diagnostics and facilitating remote monitoring. Concurrently, regulatory frameworks and payer models are evolving to address safety, real-world evidence, and outcomes-based reimbursement, which in turn influence development priorities and commercialization strategies. These dynamics are reshaping R&D investment, vendor partnerships, and clinical adoption pathways.

Looking ahead, stakeholders who can integrate clinical evidence, interoperability, and patient-centered design will be best positioned to influence care pathways. In addition, organizations that proactively align supply chain resilience with regulatory preparedness will mitigate disruption and sustain innovation pipelines. The remainder of this executive summary unpacks the structural shifts, segmentation implications, regional nuances, and recommended actions to navigate this rapidly changing landscape.

A detailed exploration of the major technological and systemic shifts reshaping clinical pathways, device design, and commercial priorities across urology care

Significant transformative shifts are reconfiguring the urology devices and platforms landscape, and these changes are both technological and systemic. First, minimally invasive and image-guided procedures have matured, driven by enhancements in endoscopic optics, laser lithotripsy modalities, and high-resolution imaging systems that raise diagnostic confidence while lowering procedural morbidity. As a result, clinical pathways are increasingly favoring interventions that accelerate recovery and enable outpatient delivery.

Second, digital and data-driven capabilities are moving from adjunct features to core product differentiators. Connected diagnostics, cloud-enabled workflow platforms, and artificial intelligence-supported image interpretation are elevating diagnostic throughput and supporting more personalized treatment planning. These capabilities also produce real-world evidence that payers and regulators are beginning to demand, thereby influencing reimbursement and adoption timelines.

Third, the locus of care is decentralizing. Ambulatory surgical centers, diagnostic centers, and home-based management are becoming more prominent, prompting redesigns in catheter technologies, portable imaging, and compact lithotripsy systems. Lastly, regulatory emphasis on post-market surveillance and interoperability standards is shaping product roadmaps and vendor partnerships, with manufacturers prioritizing compliance and data security alongside clinical performance. Taken together, these shifts create a landscape where technological excellence, interoperability, and adaptability to new care settings determine long-term competitiveness.

An analytical assessment of how the United States tariff regime implemented in 2025 is reshaping supply chains, sourcing strategies, and operational resilience in urology device manufacturing

The introduction of United States tariffs in 2025 exerts a multi-dimensional influence across the urology devices and platforms value chain. Tariff-driven cost pressures affect not only finished devices but also critical components such as imaging subsystems, laser modules, and disposable catheter materials. Consequently, procurement teams and product managers face renewed imperative to reassess supplier portfolios, re-evaluate total landed costs, and accelerate supplier qualification for alternative sources.

These dynamics also influence strategic decision-making. Manufacturers may pursue increased regional manufacturing or nearshoring to insulate operations from tariff volatility, which requires capital expenditure and modified supply chain planning. At the same time, procurement savings from consolidated sourcing or longer-term supplier agreements can partially offset higher input costs, but such arrangements require disciplined contract management and rigorous quality oversight.

Clinicians and providers experience indirect effects as procurement constraints and inventory management challenges influence device availability and lead times. To mitigate clinical disruption, organizations are prioritizing supply chain visibility tools, safety stock protocols, and multi-sourcing strategies. Finally, innovation pathways can be affected, since cost escalation prompts reallocation of R&D budgets toward modular designs that leverage standardized, tariff-exempt components. In sum, tariffs act as a catalyst for supply chain transformation, strategic operational shifts, and heightened emphasis on manufacturing resilience.

Comprehensive segmentation insights that align device categories, clinical applications, end users, procedure types, and enabling technologies to inform targeted strategic decisions

Insightful segmentation is essential to understanding product development priorities, clinical adoption, and service delivery across the urology landscape. Based on Product Type, market studies encompass Diagnostics, Endoscopes, Imaging, Lithotripsy, Urinary Catheters, and Urinary Stents; Diagnostics is further studied across Biomarker Assays, PH Meters, Urinary Flow Meters, and Urodynamic Systems; Endoscopes is examined through Cystoscopes, Nephroscopes, and Ureteroscopes; Imaging is analyzed across CT Scanning Systems, MRI Systems, Ultrasound Systems, and X Ray Systems; Lithotripsy is explored through Extracorporeal Shockwave Lithotripsy, Laser Lithotripsy, Pneumatic Lithotripsy, and Ultrasonic Lithotripsy; Urinary Catheters are reviewed across Condom Catheters, Foley Catheters, Intermittent Catheters, Nephrostomy Catheters, and Ureteral Catheters; and Urinary Stents are considered across Prostatic Stents, Ureteral Stents, and Urethral Stents.

Based on Application, the analysis spans Benign Prostatic Hyperplasia, Kidney Cancer, Kidney Stone Management, Overactive Bladder, Prostate Cancer, Urethral Stricture, Urinary Incontinence, and Urinary Tract Infection; Kidney Cancer is further delineated into Renal Cell Carcinoma, Transition Cell Carcinoma, and Wilms Tumor; Kidney Stone Management differentiates across Calcium Stones, Cystine Stones, Struvite Stones, and Uric Acid Stones; Overactive Bladder is categorized as Idiopathic and Neurogenic; Prostate Cancer is differentiated into Localized, Metastatic, and Recurrent; Urethral Stricture is classified as Iatrogenic, Idiopathic, and Traumatic; Urinary Incontinence is segmented into Mixed Incontinence, Overflow Incontinence, Stress Incontinence, and Urge Incontinence; and Urinary Tract Infection is analyzed as Complicated and Uncomplicated.

Based on End User, the study targets Ambulatory Surgical Centers, Clinics, Diagnostic Centers, Home Care, and Hospitals, illuminating how purchasing patterns and care pathways differ across those settings. Based on Procedure Type, the framework separates Invasive, Minimally Invasive, and Non Invasive approaches; Invasive procedures include Catheterization Interventions and Open Surgery; Minimally Invasive procedures encompass Endoscopic Procedures, Laparoscopic Procedures, and Percutaneous Procedures; and Non Invasive management includes Conservative Management, External Shockwave Therapy, and Imaging. Finally, based on Technology, the research evaluates Electrohydraulic, Laser, Magnetic Resonance, Optical, Pneumatic, RF, and Ultrasonic platforms; Electrohydraulic distinguishes High Frequency Electrohydraulic and Standard Electrohydraulic; Laser differentiates CO2 Laser, Greenlight Laser, Holmium Laser, and Thulium Laser; Magnetic Resonance reviews MR Spectroscopy and MRI Guided MR; Optical considers Fluorescence Optical, Narrow Band Imaging, and White Light Optical; Pneumatic assesses Ballistic Pneumatic and Vibratory Pneumatic; RF examines Bipolar RF and Monopolar RF; and Ultrasonic explores High Intensity Ultrasonic and Low Intensity Ultrasonic. This layered segmentation enables targeted strategy development that aligns product features with clinical needs and care settings.

Regional strategic perspectives revealing how distinct regulatory, reimbursement, and care delivery priorities in the Americas, EMEA, and Asia-Pacific influence adoption and commercialization

Regional dynamics shape adoption timelines, reimbursement structures, and regulatory expectations, producing varied strategic imperatives across global markets. In the Americas, clinical emphasis on outpatient shift and bundled payment models incentivizes devices and platforms that reduce procedural cost and facilitate rapid recovery, while strong private payer participation accelerates uptake of premium technologies that demonstrate measurable outcomes. As a result, manufacturers targeting this region prioritize clinical-economic evidence and streamlined supply relationships.

In Europe, Middle East & Africa, heterogeneous regulatory pathways and public payer dominance create a complex environment where tendering mechanisms and national health technology assessments drive procurement decisions. Manufacturers operating across this region must balance centralized regulatory approvals with localized health economic arguments and partnerships with public providers. Meanwhile, medical infrastructure disparities across subregions necessitate modular product offerings and flexible service models.

In the Asia-Pacific region, rapid investment in healthcare capacity, a growing middle-class patient base, and a strong appetite for medical tourism create favorable conditions for advanced surgical platforms and diagnostic imaging. However, local manufacturing capabilities and cost-sensitive procurement practices often favor regional supply partnerships and technology transfer arrangements. Across all regions, interoperability, post-market surveillance, and local clinical evidence generation remain cross-cutting priorities that influence adoption and long-term product success.

A nuanced examination of how device manufacturers and platform providers are deploying technology, partnerships, and service models to strengthen competitive advantage

Key companies in the urology devices and platforms space are differentiating themselves through a combination of technological leadership, clinical partnerships, and integrated service offerings. Market-leading manufacturers increasingly couple capital equipment with consumables and data services to create recurring revenue streams and deepen customer relationships. This shift toward solution-oriented business models emphasizes long-term service agreements, remote monitoring capabilities, and bundled purchasing options that address provider priorities for reliability and total cost of ownership.

Strategic collaborations between device developers, digital health firms, and academic clinical centers are accelerating product validation and enhancing clinical utility. In parallel, targeted acquisitions and licensing arrangements enable faster access to complementary technologies such as advanced imaging modules, AI-enabled analytics, and novel lithotripsy modalities. Competitive differentiation arises from the ability to translate technological innovation into validated clinical outcomes and streamlined workflows that reduce procedural complexity.

Operational excellence also matters: firms with resilient supply chains, robust regulatory teams, and scalable manufacturing processes can respond faster to demand shifts and tariff-driven disruptions. Finally, customer-centric commercial strategies that include clinician training programs, procedure optimization support, and real-world evidence sharing will continue to influence procurement decisions and long-term adoption trajectories.

Actionable strategic imperatives for leaders to strengthen supply chain resilience, accelerate digital integration, and align commercial models with evolving provider needs

Industry leaders must act decisively to capture value and mitigate risk as the urology landscape evolves. First, diversify supply chain footprints and qualify alternative component suppliers to reduce exposure to tariff and geopolitical shocks while investing selectively in nearshoring where it improves lead times and quality control. Second, prioritize modular product designs that enable component standardization and cost-effective upgrades, thereby extending product lifecycles and simplifying regulatory submissions.

Third, invest in digital capabilities that enhance diagnostic precision, procedural guidance, and post-procedure monitoring. Integrating cloud-based data platforms and AI-supported analytics will not only improve clinical outcomes but also generate the evidence required for payer engagement. Fourth, design commercialization strategies that reflect end-user heterogeneity: tailor product configurations and service levels for ambulatory surgical centers, hospitals, diagnostic centers, clinics, and home care settings to maximize adoption.

Fifth, engage early with regulatory bodies and health technology assessors to align study designs with evidentiary expectations and expedite reimbursement pathways. Sixth, expand clinician training and proctoring programs to shorten adoption curves and demonstrate real-world value. Finally, develop flexible pricing and contracting models that support outcomes-based arrangements and lifecycle service commitments, enabling customers to share risk and align incentives across the care continuum.

A transparent and multi-method research approach combining clinician input, regulatory review, and supply chain analysis to validate strategic conclusions and recommendations

The research methodology underpinning this analysis combines multiple evidence streams to ensure robust, actionable insights. Primary research included structured interviews and advisory engagements with practicing urologists, hospital procurement executives, ambulatory care administrators, and device development leaders to capture frontline perspectives on clinical needs, adoption barriers, and procurement drivers. These qualitative inputs were complemented by a systematic review of recent clinical literature, regulatory filings, and procedural guidelines to ground findings in current practice and safety requirements.

Secondary analysis encompassed technology landscape mapping, patent review, and device labeling assessments to identify feature differentials and technological trajectories. Supply chain and manufacturing analyses examined component sourcing, regulatory compliance pathways, and tariff exposure to evaluate operational risks. Data triangulation ensured consistency across sources, while expert validation sessions with multi-disciplinary panels tested assumptions and refined strategic recommendations.

In addition, case-based scenario planning was used to explore the implications of policy shifts, reimbursement changes, and technology disruptions on adoption timelines and commercial success. Throughout the methodology, emphasis was placed on transparent documentation of data sources, qualification criteria for interviewees, and the limitations inherent to evolving clinical and regulatory environments.

A compelling conclusion that synthesizes key insights and underscores strategic priorities for stakeholders seeking to navigate complexity and capture growth opportunities

In closing, the urology devices and platforms sector is entering a period characterized by both significant opportunity and heightened complexity. Technological advances in imaging, endoscopy, and lithotripsy are enabling safer, more effective interventions, while digital tools and connectivity are transforming diagnostics and post-procedural management. At the same time, external pressures such as tariff regimes, supply chain constraints, and evolving reimbursement expectations demand proactive strategic responses from manufacturers and providers alike.

Organizations that succeed will be those that integrate clinical evidence generation, adaptable product architectures, and resilient operational models. Equally important will be the capacity to customize offerings to disparate care settings and regional market nuances, and to demonstrate measurable clinical and economic value to payers and health systems. For stakeholders willing to invest in interoperability, clinician engagement, and modular innovation, the changing landscape presents clear pathways to competitive differentiation and sustainable growth.

The insights and recommendations provided here are intended to inform near-term tactical decisions and longer-term strategic planning, empowering leaders to navigate uncertainty while capitalizing on the most promising avenues for clinical impact and commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven diagnostics for early detection of prostate cancer and kidney stones
  • 5.2. Adoption of teleurology platforms to deliver remote urological consultations and patient monitoring
  • 5.3. Development of minimally invasive robotic-assisted surgical systems tailored to complex urological procedures
  • 5.4. Growth of wearable urinary incontinence monitoring devices offering real-time analytics for treatment optimization
  • 5.5. Launch of advanced smart catheter solutions designed to reduce infections and enhance patient comfort
  • 5.6. Expansion of point-of-care molecular testing platforms enabling rapid urinary tract infection diagnosis
  • 5.7. Utilization of cloud-based patient management software for integrated urology care coordination and analytics

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urology Care Devices & Platforms Market, by Product Type

  • 8.1. Diagnostics
    • 8.1.1. Biomarker Assays
    • 8.1.2. PH Meters
    • 8.1.3. Urinary Flow Meters
    • 8.1.4. Urodynamic Systems
  • 8.2. Endoscopes
    • 8.2.1. Cystoscopes
    • 8.2.2. Nephroscopes
    • 8.2.3. Ureteroscopes
  • 8.3. Imaging
    • 8.3.1. CT Scanning Systems
    • 8.3.2. MRI Systems
    • 8.3.3. Ultrasound Systems
    • 8.3.4. X Ray Systems
  • 8.4. Lithotripsy
    • 8.4.1. Extracorporeal Shockwave Lithotripsy
    • 8.4.2. Laser Lithotripsy
    • 8.4.3. Pneumatic Lithotripsy
    • 8.4.4. Ultrasonic Lithotripsy
  • 8.5. Urinary Catheters
    • 8.5.1. Condom Catheters
    • 8.5.2. Foley Catheters
    • 8.5.3. Intermittent Catheters
    • 8.5.4. Nephrostomy Catheters
    • 8.5.5. Ureteral Catheters
  • 8.6. Urinary Stents
    • 8.6.1. Prostatic Stents
    • 8.6.2. Ureteral Stents
    • 8.6.3. Urethral Stents

9. Urology Care Devices & Platforms Market, by Application

  • 9.1. Benign Prostatic Hyperplasia
  • 9.2. Kidney Cancer
    • 9.2.1. Renal Cell Carcinoma
    • 9.2.2. Transition Cell Carcinoma
    • 9.2.3. Wilms Tumor
  • 9.3. Kidney Stone Management
    • 9.3.1. Calcium Stones
    • 9.3.2. Cystine Stones
    • 9.3.3. Struvite Stones
    • 9.3.4. Uric Acid Stones
  • 9.4. Overactive Bladder
    • 9.4.1. Idiopathic
    • 9.4.2. Neurogenic
  • 9.5. Prostate Cancer
    • 9.5.1. Localized
    • 9.5.2. Metastatic
    • 9.5.3. Recurrent
  • 9.6. Urethral Stricture
    • 9.6.1. Iatrogenic
    • 9.6.2. Idiopathic
    • 9.6.3. Traumatic
  • 9.7. Urinary Incontinence
    • 9.7.1. Mixed Incontinence
    • 9.7.2. Overflow Incontinence
    • 9.7.3. Stress Incontinence
    • 9.7.4. Urge Incontinence
  • 9.8. Urinary Tract Infection
    • 9.8.1. Complicated
    • 9.8.2. Uncomplicated

10. Urology Care Devices & Platforms Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Home Care
  • 10.5. Hospitals

11. Urology Care Devices & Platforms Market, by Procedure Type

  • 11.1. Invasive
    • 11.1.1. Catheterization Interventions
    • 11.1.2. Open Surgery
  • 11.2. Minimally Invasive
    • 11.2.1. Endoscopic Procedures
    • 11.2.2. Laparoscopic Procedures
    • 11.2.3. Percutaneous Procedures
  • 11.3. Non Invasive
    • 11.3.1. Conservative Management
    • 11.3.2. External Shockwave Therapy
    • 11.3.3. Imaging

12. Urology Care Devices & Platforms Market, by Technology

  • 12.1. Electrohydraulic
    • 12.1.1. High Frequency Electrohydraulic
    • 12.1.2. Standard Electrohydraulic
  • 12.2. Laser
    • 12.2.1. CO2 Laser
    • 12.2.2. Greenlight Laser
    • 12.2.3. Holmium Laser
    • 12.2.4. Thulium Laser
  • 12.3. Magnetic Resonance
    • 12.3.1. MR Spectroscopy
    • 12.3.2. MRI Guided MR
  • 12.4. Optical
    • 12.4.1. Fluorescence Optical
    • 12.4.2. Narrow Band Imaging
    • 12.4.3. White Light Optical
  • 12.5. Pneumatic
    • 12.5.1. Ballistic Pneumatic
    • 12.5.2. Vibratory Pneumatic
  • 12.6. RF
    • 12.6.1. Bipolar RF
    • 12.6.2. Monopolar RF
  • 12.7. Ultrasonic
    • 12.7.1. High Intensity Ultrasonic
    • 12.7.2. Low Intensity Ultrasonic

13. Urology Care Devices & Platforms Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Urology Care Devices & Platforms Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Urology Care Devices & Platforms Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Boston Scientific Corporation
    • 16.3.2. Olympus Corporation
    • 16.3.3. Medtronic plc
    • 16.3.4. Coloplast A/S
    • 16.3.5. Becton, Dickinson and Company
    • 16.3.6. Teleflex Incorporated
    • 16.3.7. ConvaTec Group plc
    • 16.3.8. Intuitive Surgical, Inc.
    • 16.3.9. Stryker Corporation
    • 16.3.10. Johnson & Johnson

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. UROLOGY CARE DEVICES & PLATFORMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. UROLOGY CARE DEVICES & PLATFORMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UROLOGY CARE DEVICES & PLATFORMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEUROGENIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEUROGENIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEUROGENIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEUROGENIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEUROGENIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL UROLOGY CARE DEVICES & PLATFORMS M